MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$121,169K
Trade and other
receivables, net
$17,763K
Inventories, net
$6,169K
Prepaid expenses and
other current assets
$4,168K
Total current assets
$149,269K
Right-of-use assets, net
$4,621K
Property and equipment,
net
$3,893K
Other non-current
assets
$2,642K
Total assets
$160,425K
Accumulated deficit
-$446,998K
Total liabilities and
stockholders deficit
$160,425K
Total stockholders
deficit
-$33,662K
Additional paid-in capital
$413,214K
Common stock, 0.001 par
value. authorized...
$122K
Total liabilities
$194,087K
Liability related to the
sale of future...
$62,023K
Total current
liabilities
$47,608K
Notes payable, net
$27,519K
Royalty obligations,
net
$25,941K
Deferred revenue, net of
current portion
$19,390K
Other non-current
liabilities
$7,269K
Lease liabilities
$4,337K
Accounts payable
$29,862K
Loans payable,
current
$9,994K
Accrued expenses
$5,029K
Deferred revenue,
current
$1,092K
Liability related to the
sale of future...
$1,000K
Lease liabilities,
current
$631K
Back
Back
Balance Sheet
source: myfinsight.com
Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics, Inc. (AQST)